
Get exclusive money-saving offers and guides
Straight to your inbox
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Avecho Biotechnology Limited is a biotechnology business based in Australia. Avecho Biotechnology shares (AVE) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Avecho Biotechnology has a trailing 12-month revenue of around $258,906.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.002 - $0.038 |
---|---|
50-day moving average | $0.0244 |
200-day moving average | $0.0156 |
Target price | $1.72 |
PE ratio | 16 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $0.001 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Avecho Biotechnology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avecho Biotechnology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avecho Biotechnology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Avecho Biotechnology shares trade at around 16x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Avecho Biotechnology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 million (£614,741).
The EBITDA is a measure of a Avecho Biotechnology's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $258,906 |
---|---|
Gross profit TTM | $4 million |
Return on assets TTM | -32.96% |
Return on equity TTM | -45.58% |
Profit margin | 0% |
Book value | 0.003 |
Market capitalisation | $42.1 million |
TTM: trailing 12 months
We're not expecting Avecho Biotechnology to pay a dividend over the next 12 months.
Avecho Biotechnology's shares were split on 22 April 1999.
Over the last 12 months, Avecho Biotechnology's shares have ranged in value from as little as $0.002 up to $0.038. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Avecho Biotechnology's is 2.4601. This would suggest that Avecho Biotechnology's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production, Human Health, and Animal Health and Nutrition segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company serves customers in Australia, Switzerland, the United States, India, Japan, China, Singapore, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited is based in Melbourne, Australia.
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
We explain everything you need to make your own retro arcade machine, built around the super-flexible Raspberry Pi.
Beat the banks, find the best exchange rates and avoid fees when you send money abroad from Australia.
All the key info you need to know to sell shares you inherited or received as a gift.
Steps to owning and managing Roblox shares.
Steps to owning and managing Zebit shares.
Steps to owning and managing CleanSpace shares.
Steps to owning and managing Benz Mining shares.